Surgery Partners (SGRY) Cash from Financing Activities (2014 - 2026)

Surgery Partners' Cash from Financing Activities history runs 13 years deep, the most recent figure standing at -$55.9 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 285.1% year-over-year to -$55.9 million; the TTM figure through Mar 2026 stood at -$143.4 million (down 155.05% YoY), while the FY2025 annual figure was -$57.3 million, down 121.87% from the prior year.
• Cash from Financing Activities came in at -$55.9 million for Q1 2026 at Surgery Partners, down from $59.2 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $193.1 million in Q4 2022 to a low of -$84.1 million in Q3 2025.
• A 5-year average of $2.1 million and a median of -$41.2 million in 2023 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities soared 486.94% in 2024 and slumped 1052.05% in 2025, its largest moves.
• Surgery Partners' Cash from Financing Activities stood at $193.1 million in 2022, then sank by 123.1% to -$44.6 million in 2023, then surged by 207.62% to $48.0 million in 2024, then grew by 23.33% to $59.2 million in 2025, then sank by 194.43% to -$55.9 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$55.9 million, $59.2 million, and -$84.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison